FDA Inspection 1125537 — Siegfried St. Vulbas SAS
The FDA completed an inspection of Siegfried St. Vulbas SAS on Nov 7, 2019 in Saint-Vulbas. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint-Vulbas (France)
Additional details
Mutual Recognition Agreement (MRA)